N-Nitroso-N-methylbenzylamine (NBMA)(NMBzA)
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

937-40-6N-Nitroso-N-methylbenzylamine (NBMA)(NMBzA)

● Auf Lager

Katalog-Nr.::VE006112
CAS-Nr.::937-40-6
Summenformel::C8H10N2O
Molare Masse::150.18 g/mol

Zusätzliche Informationen zu CAS 937-40-6

Parent drug

Rivaroxaban

IUPAC-Name

N-Methyl-N-nitrosobenzenemethanamine

Pharmakopöe-Synonyme

N/A

Other Synonyms

Methylbenzylnitrosamine; N-benzyl-N-methylnitrous amide; Methyl-benzyl-nitrosoamin; Benzylamine, N-methyl-N-nitroso-; 1-Benzyl-1-methyl-2-oxohydrazine

SMILES

CN(CC1=CC=CC=C1)N=O

InChI

InChI=1S/C8H10N2O/c1-10(9-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Beschreibung

N-Nitroso-N-methylbenzylamine is an N-nitroso derivative of the secondary amine present in Rivaroxaban | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Rivaroxaban production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

References

Hsia, C. -C ., et al. ?Enhancement of Formation of the Esophageal Carcinogen Benzylmethylnitrosamine from Its Precursors by Candida Albicans.? Proceedings of the National Academy of Sciences, vol. 78, no. 3, Mar. 1981, pp. 1878?81, https://doi.org/10.1073/pnas.78.3.1878.?

Angebot anfordern

*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Dieses Feld wird bei der Anzeige des Formulars ausgeblendet
Products quotation
Name
Url
 
Dieses Feld wird bei der Anzeige des Formulars ausgeblendet
Dieses Feld wird bei der Anzeige des Formulars ausgeblendet